Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Mel Sorensen

President and Chief Executive Officer
Pharmaceutical Sciences
Galera Therapeutics Inc.
United States of America


Dr. Sorensen has been President and Chief Executive Officer of Galera Therapeutics since 2012. He is a Medical Oncologist who has spent 7-8 years each in patient care (oncology fellowship at the Mayo Clinic), in academia (Senior Investigator at the National Institutes of Health), and in leadership positions in clinical development in the pharmaceutical industry (Bayer and GlaxoSmithKline).  Since 2004, he has served as President & CEO of private venture-funded biotechs. Dr. Sorensen has raised over $150 million in several private financing rounds and has led licensing deals for multiple preclinical and clinical-stage compounds. He also serves as Chairman of other biotech companies, including Oncopia Therapeutics and OncoFusion Therapeutics, and is an advisor to the Biomarkers Consortium of the National Institutes of Health and to the Irish Cancer Society.    

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters  

Global Experts from United States of America

Global Experts in Subject